Upgrade to SI Premium - Free Trial

BioVie Inc. (BIVI)

2.00 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/28/25 *Est.)

Latest Headlines

Form 4 BIOVIE INC. For: Aug 28 Filed by: Palumbo Joseph M August 28, 2026 9:02 PM - SEC Filing Form 4 BIOVIE INC. For: Aug 28 Filed by: Chappell Amy Suzon August 28, 2026 9:01 PM - SEC Filing Form 4 BIOVIE INC. For: Aug 28 Filed by: KIM JOANNE WENDY August 28, 2026 8:58 PM - SEC Filing Form 4 BIOVIE INC. For: Aug 27 Filed by: DO CUONG V August 28, 2026 8:58 PM - SEC Filing New to The Street Broadcasts Today Across Bloomberg Television U.S., Latin America and MENA at 6:30 PM ET August 22, 2026 10:41 AM - StreetInsider Form SCHEDULE 13G BIOVIE INC. Filed by: Alta Partners LLC August 19, 2026 4:09 PM - SEC Filing Form S-1/A BIOVIE INC. August 14, 2026 5:23 PM - SEC Filing First Phosphate and BioVie Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV August 14, 2026 9:01 AM - StreetInsider Form 10-K BIOVIE INC. For: Jun 30 August 13, 2026 6:04 AM - SEC Filing New to The Street Show 766 Broadcasts Tonight at 6:30 PM ET on Bloomberg Television, Featuring BioVie's Bezisterim Parkinson's Disease Clinical Results August 8, 2026 12:01 PM - StreetInsider Form SCHEDULE 13G/A BIOVIE INC. Filed by: MORGAN STANLEY August 7, 2026 5:21 PM - SEC Filing Form SCHEDULE 13G BIOVIE INC. Filed by: MORGAN STANLEY August 7, 2026 5:13 PM - SEC Filing Form FWP BIOVIE INC. Filed by: BIOVIE INC. August 7, 2026 4:47 PM - SEC Filing Join Biovie's Exclusive Live Investor Webinar: Inside the SUNRISE-PD Topline Results August 7, 2026 9:01 AM - StreetInsider Form FWP BIOVIE INC. Filed by: BIOVIE INC. August 6, 2026 5:20 PM - SEC Filing Form FWP BIOVIE INC. Filed by: BIOVIE INC. August 6, 2026 7:45 AM - SEC Filing Form S-1/A BIOVIE INC. August 6, 2026 7:41 AM - SEC Filing Form 8-K BIOVIE INC. For: Aug 06 August 6, 2026 7:35 AM - SEC Filing BioVie's bezisterim shows Phase 2 gains in Parkinson's trial August 6, 2026 7:30 AM - StreetInsider BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease August 6, 2026 7:30 AM - Globe NewsWire Form S-1/A BIOVIE INC. July 31, 2026 5:29 PM - SEC Filing Form S-1 BIOVIE INC. July 17, 2026 5:21 PM - SEC Filing Form EFFECT BIOVIE INC. June 30, 2026 6:06 AM - SEC Filing Form S-3 BIOVIE INC. June 18, 2026 5:21 PM - SEC Filing Full Article List